뇌손상 환자의 야간뇨에 대한 경구 데스모프레신의 효과 및 안전성
Effect and Safety of Oral Desmopressin for Nocturia in Brain Injured Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To assess the effect of oral desmopressin administration for nocturia and sleeping in brain injured patients and to confirm its safety.Method: 20 brain injured patients waking up more than twice a night for urination during sleeping have been subjected to take 0.1 mg of desmopressin at 9 p.m. everyday for 30 days. To analyze the effect of the drug before and after its administration, the frequency of patient's awakening for urination, duration of time to first urination after sleeping, total urination volume during sleeping and Pittsburgh sleep quality index (PSQI) were evaluated. All newly found symptoms one month after taking the medication were recorded to confirm the safety of the drug. Results: After taking the medication, the mean urination frequency of 20 patients was reduced from 2.4 to 1.4, the mean duration of time to the first urination after sleeping was increased from 3.4 hours to 4.9 hours (p＜0.01). The mean PSQI score of 20 patients was decreased from 9.7 to 4.8 (p＜0.01). 2 patients had side effects (hyponatremia, headache).Conclusion: The oral administration of desmopressin was relatively safe and effective on brain injured patients with nocturia.
Abstract
Objective: To assess the effect of oral desmopressin administration for nocturia and sleeping in brain injured patients and to confirm its safety.Method: 20 brain injured patients waking up more than twice a night for urination during sleeping have been subjected to take 0.1 mg of desmopressin at 9 p.m. everyday for 30 days. To analyze the effect of the drug before and after its administration, the frequency of patient's awakening for urination, duration of time to first urination after sleeping, total urination volume during sleeping and Pittsburgh sleep quality index (PSQI) were evaluated. All newly found symptoms one month after taking the medication were recorded to confirm the safety of the drug. Results: After taking the medication, the mean urination frequency of 20 patients was reduced from 2.4 to 1.4, the mean duration of time to the first urination after sleeping was increased from 3.4 hours to 4.9 hours (p＜0.01). The mean PSQI score of 20 patients was decreased from 9.7 to 4.8 (p＜0.01). 2 patients had side effects (hyponatremia, headache).Conclusion: The oral administration of desmopressin was relatively safe and effective on brain injured patients with nocturia.
참고문헌 (25)
- Marinkovic S., "Voiding and sexual dysfunction after cerebrovascular accidents", J Urol, 165, pp.359~370 (2001)
- Brittain K. R., "Prevalence and impact of urinary symptoms among community- dwelling stroke survivors", Stroke, 31, pp.886~891 (2000)
- Oh B. M., "Lower urinary tract symptoms in chronic stroke survivors: frequency and impact on quality of life", J Korean Acad Rehab Med, 29, pp.450~456 (2005)
- Asplund R., "Nocturia, nocturnal polyuria, and sleep quality in the eldery", J Psychosom Res, 56, pp.517~525 (2004)
- Kuo H. C., "Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years", Urology, 59, pp.485~489 (2002)
- Lose G., "Kerrebroeck PV. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women", Am J Obstet Gynecol, 189, pp.1106~1113 (2003)
- Johnson T. M., "Oral ddAVP for nighttime urinary incontinence in characterized nursing home residents: a pilot study", J Am Med Dir Assoc, 7, pp.6~11 (2006)
- van Kerrebroeck P., "Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study", Eur Urol, 52, pp.221~229 (2007)
- Naghizadeh S., "Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy", Eur Urol, 48, pp.819~825 (2005)
- Robinson D., "Antidiuresis: a new concept in managing female daytime urinary incontinence", BJU Int, 93, pp.996~1000 (2004)
- Aloba O. O., "Validity of the Pittsburgh Sleep Quality Index among Nigerian university students", Sleep Med, 8, pp.266~270 (2007)
- Carpenter J. S., "Psychometric evaluation of the Pittsburgh Sleep Quality Index", J Psychosom Res, 45, pp.5~13 (1998)
- Kim H. A., "An evaluation of apnea-hypopnea index, sleep questionnaires, oropharyngeal findings and cephalometric parameters in patients with snoring", J Korean Neurol Assoc, 23, pp.215~221 (2005)
- Cho Y. W., "Sleep disorders in maintenance dialysis patients with end-stage renal disease", J Korean Neurol Assoc, 21, pp.492~497 (2003)
- Bang K. M., "Quality of sleep and health-related quality of life in patients with major mental disorders", J Korean Soc Biol Ther Psychiatry, 11, pp.138~149 (2000)
- Abelson J. L., "Dose response of arginine vasopressin to the CCK-B agonist pentagastrin", Neuropsychopharmacology, 24, pp.161~169 (2001)
- Giekoop J. G., "Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation", Psychiatry Res, 141, pp.201~211 (2006)
- Gribel G., "Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders", Curr Pharm Des, 11, pp.1549~1559 (2005)
- Kasper D. L., "Harrison's principles of internal medicine, 16th ed", pp.2102~ (2004), McGraw-Hill
- Gill J. C., "Treatment of urgent bleeding in von Willebrand disease", Thromb Res, 120, pp.21~25 (2007)
- Hirayama A., "Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria", Urology, 68, pp.19~23 (2006)
- Sakakibara R., "Nocturnal polyuria with abnormal circadian rhythm of plasma arginine vasopressin in post-stroke patients", Intern Med, 44, pp.281~284 (2005)
- Shindel A., "Hyponatremia associated with desmopressin for the treatment of nocturnal polyuria", Urology, 60, pp.344~ (2002)
- Kelleher H. B., "Severe hyponatremia due to desmopressin", J Emerg Med, 30, pp.45~47 (2006)
- Spinazze S., "Metabolic emergencies", Crit Rev in Oncol Hematol, 58, pp.79~89 (2006)